HOWL
Werewolf Therapeutics Inc
NASDAQ: HOWL · HEALTHCARE · BIOTECHNOLOGY
$0.68
-8.11% today
Updated 2026-04-29
Market cap
$33.05M
P/E ratio
—
P/S ratio
10.21x
EPS (TTM)
$-1.33
Dividend yield
—
52W range
$1 – $2
Volume
0.4M
Werewolf Therapeutics Inc (HOWL) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-9.54M | $-18.62M | $-42.88M | $-40.60M | $-32.61M | $-56.19M | $-60.29M |
| Capital expenditures | $266000.00 | $560000.00 | $498000.00 | $3.61M | $769000.00 | $254000.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $559000.00 | $632000.00 | $4.09M | $7.40M | $8.01M | $8.83M | $6.25M |
| Free cash flow | $-9.81M | $-19.18M | $-43.37M | $-44.21M | $-33.38M | $-56.44M | $-60.29M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | $66.05M | $-28.30M | — | — | — |